Advertisement Ajinomoto completes acquisition of Althea Technologies - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Ajinomoto completes acquisition of Althea Technologies

Ajinomoto has completed the acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services.

All the capital stock of Althea is purchased by Ajinomoto at closing for approximately $175m.

Althea will turn out to be a fully consolidated subsidiary of Ajinomoto, doing business as Ajinomoto Althea.

Ajinomoto manufactures pharmaceuticals, specialty chemicals, seasonings, processed foods, beverages and amino acids.